Print（PDF/151KB） Jun. 03, 2024 Corporate
Sumitomo Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officer and Other Key Positions
Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following organizational realignment and changes in the positions assumed by Executive Officer and other key positions.
I. Organizational Realignment (effective June 18, 2024)
Corporate Department
Following the absorption-type company split of the Frontier Business to FrontAct Co.,
Ltd., Frontier Business Office is dissolved.
*The following press release has been issued in relation to this organizational realignment.
- Notice of Company Split (Simplified Absorption-type Company Split) of the Frontier Business and Notice of Business Acquisition by a Wholly-Owned Subsidiary of the Company (May 9, 2024) https://www.sumitomo-pharma.com/news/assets/pdf/ene20240509.pdf
II. Change in the Positions Assumed by Executive Officer (effective June 18, 2024)
| Position as of June 18, 2024 | Current position | Name |
|---|---|---|
| Member, Board of Directors,
Managing Executive Officer Global Data Design Office; Legal Affairs; Intellectual Property; IT Management & Digital Transformation |
Member, Board of Directors,
Managing Executive Officer Global Data Design Office; Legal Affairs; Intellectual Property; IT Management & Digital Transformation; Frontier Business Office |
Hiroyuki Baba |
*Hiroyuki Baba will depart from Member of the Board of Directors upon the conclusion of the general shareholders’ meeting scheduled to be held on June 25, 2024. The following press release has been issued in relation to departing Member of the Board of Directors.
- Sumitomo Pharma Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers (May 14, 2024) https://www.sumitomo-pharma.com/news/assets/pdf/ene20240514.4.pdf
III. Changes in Personnel
(1) Effective June 18, 2024
Corporate Department
| Position as of June 18, 2024 | Current position | Name |
|---|---|---|
| Representative Director, President and CEO, FrontAct Co., Ltd. | Vice President, Head of Frontier Business Office | Takehiko Nomura |
(2) Effective June 25, 2024
Corporate Department
| Position as of June 25, 2024 | Current position | Name |
|---|---|---|
| Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant Vice President, Head of Regenerative & Cellular Medicine Office |
Vice President, Head of Regenerative & Cellular Medicine Office | Tomokazu Nagano |
Inquiries from the Press